Orthopediatrics Corp (KIDS) - Total Assets
Based on the latest financial reports, Orthopediatrics Corp (KIDS) holds total assets worth $502.19 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Orthopediatrics Corp (KIDS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Orthopediatrics Corp - Total Assets Trend (2014–2025)
This chart illustrates how Orthopediatrics Corp's total assets have evolved over time, based on quarterly financial data. See KIDS total equity for net asset value and shareholders' equity analysis.
Orthopediatrics Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
Orthopediatrics Corp's total assets of $502.19 Million consist of 50.4% current assets and 49.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.8% |
| Accounts Receivable | $53.84 Million | 10.6% |
| Inventory | $133.79 Million | 26.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $77.71 Million | 15.3% |
| Goodwill | $109.27 Million | 21.5% |
Asset Composition Trend (2014–2025)
This chart illustrates how Orthopediatrics Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Orthopediatrics Corp.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Orthopediatrics Corp's current assets represent 50.4% of total assets in 2025, a decrease from 76.8% in 2014.
- Cash Position: Cash and equivalents constituted 3.8% of total assets in 2025, down from 18.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 2.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 26.3% of total assets.
Orthopediatrics Corp Competitors by Total Assets
Key competitors of Orthopediatrics Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Orthopediatrics Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.21 | 6.19 | 4.79 |
| Quick Ratio | 2.37 | 2.99 | 2.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $198.68 Million | $194.55 Million | $115.06 Million |
Orthopediatrics Corp - Advanced Valuation Insights
This section examines the relationship between Orthopediatrics Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 1.02 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | $508.63 Million |
| Market Capitalization | $516.78 Million USD |
Valuation Analysis
Above Book Valuation: The market values Orthopediatrics Corp's assets above their book value (1.02x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Orthopediatrics Corp's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Orthopediatrics Corp (2014–2025)
The table below shows the annual total assets of Orthopediatrics Corp from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $508.63 Million | +7.49% |
| 2024-12-31 | $473.21 Million | +7.86% |
| 2023-12-31 | $438.75 Million | +2.58% |
| 2022-12-31 | $427.73 Million | +38.69% |
| 2021-12-31 | $308.40 Million | -5.06% |
| 2020-12-31 | $324.83 Million | +66.95% |
| 2019-12-31 | $194.56 Million | +73.56% |
| 2018-12-31 | $112.11 Million | +36.21% |
| 2017-12-31 | $82.30 Million | +168.29% |
| 2016-12-31 | $30.68 Million | -0.05% |
| 2015-12-31 | $30.69 Million | -14.34% |
| 2014-12-31 | $35.83 Million | -- |
About Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sp… Read more